QQQ   272.85 (-3.47%)
AAPL   112.07 (-3.89%)
MSFT   204.17 (-4.26%)
FB   268.86 (-5.09%)
GOOGL   1,515.99 (-5.18%)
AMZN   3,177.89 (-3.30%)
TSLA   408.36 (-3.84%)
NVDA   509.50 (-4.92%)
BABA   309.67 (-2.36%)
CGC   18.34 (-1.71%)
GE   7.44 (+4.79%)
MU   50.16 (-3.46%)
AMD   76.75 (-2.70%)
T   26.50 (-1.56%)
F   7.73 (-2.40%)
ACB   3.81 (-4.75%)
GILD   58.93 (-1.80%)
NFLX   487.83 (-0.22%)
NIO   27.52 (-3.23%)
BA   148.63 (-4.26%)
DIS   118.76 (-3.69%)
QQQ   272.85 (-3.47%)
AAPL   112.07 (-3.89%)
MSFT   204.17 (-4.26%)
FB   268.86 (-5.09%)
GOOGL   1,515.99 (-5.18%)
AMZN   3,177.89 (-3.30%)
TSLA   408.36 (-3.84%)
NVDA   509.50 (-4.92%)
BABA   309.67 (-2.36%)
CGC   18.34 (-1.71%)
GE   7.44 (+4.79%)
MU   50.16 (-3.46%)
AMD   76.75 (-2.70%)
T   26.50 (-1.56%)
F   7.73 (-2.40%)
ACB   3.81 (-4.75%)
GILD   58.93 (-1.80%)
NFLX   487.83 (-0.22%)
NIO   27.52 (-3.23%)
BA   148.63 (-4.26%)
DIS   118.76 (-3.69%)
QQQ   272.85 (-3.47%)
AAPL   112.07 (-3.89%)
MSFT   204.17 (-4.26%)
FB   268.86 (-5.09%)
GOOGL   1,515.99 (-5.18%)
AMZN   3,177.89 (-3.30%)
TSLA   408.36 (-3.84%)
NVDA   509.50 (-4.92%)
BABA   309.67 (-2.36%)
CGC   18.34 (-1.71%)
GE   7.44 (+4.79%)
MU   50.16 (-3.46%)
AMD   76.75 (-2.70%)
T   26.50 (-1.56%)
F   7.73 (-2.40%)
ACB   3.81 (-4.75%)
GILD   58.93 (-1.80%)
NFLX   487.83 (-0.22%)
NIO   27.52 (-3.23%)
BA   148.63 (-4.26%)
DIS   118.76 (-3.69%)
QQQ   272.85 (-3.47%)
AAPL   112.07 (-3.89%)
MSFT   204.17 (-4.26%)
FB   268.86 (-5.09%)
GOOGL   1,515.99 (-5.18%)
AMZN   3,177.89 (-3.30%)
TSLA   408.36 (-3.84%)
NVDA   509.50 (-4.92%)
BABA   309.67 (-2.36%)
CGC   18.34 (-1.71%)
GE   7.44 (+4.79%)
MU   50.16 (-3.46%)
AMD   76.75 (-2.70%)
T   26.50 (-1.56%)
F   7.73 (-2.40%)
ACB   3.81 (-4.75%)
GILD   58.93 (-1.80%)
NFLX   487.83 (-0.22%)
NIO   27.52 (-3.23%)
BA   148.63 (-4.26%)
DIS   118.76 (-3.69%)
Log in
NASDAQ:NKTR

Nektar Therapeutics Price Target, Predictions & Analyst Ratings

$15.94
-0.54 (-3.28 %)
(As of 10/28/2020 03:51 PM ET)
Add
Compare
Today's Range
$15.82
Now: $15.94
$16.37
50-Day Range
$16.28
MA: $17.99
$20.34
52-Week Range
$13.63
Now: $15.94
$28.60
Volume38,626 shs
Average Volume1.40 million shs
Market Capitalization$2.85 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.82

Analyst Ratings

Nektar Therapeutics (NASDAQ:NKTR) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
15 Wall Street analysts have issued ratings and price targets for Nektar Therapeutics in the last 12 months. Their average twelve-month price target is $31.23, predicting that the stock has a possible upside of 95.93%. The high price target for NKTR is $80.00 and the low price target for NKTR is $17.00. There are currently 1 sell rating, 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
NKTR Consensus Rating: BuyBuyBuyBuy
NKTR Consensus Rating Score: 2.532.532.502.59
NKTR Analyst Ratings: 1 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
NKTR Consensus Price Target: $31.23$31.23$32.00$32.81
NKTR Price Target Upside: 95.93% upside54.30% upside52.91% upside63.36% upside

Nektar Therapeutics (NASDAQ:NKTR) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nektar Therapeutics (NASDAQ:NKTR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/14/2020JPMorgan Chase & Co.Initiated CoverageNeutral$26.00High
8/14/2020SVB LeerinkLower Price TargetMarket Perform$18.00 ➝ $17.00Medium
8/7/2020OppenheimerReiterated RatingHold$25.00High
6/10/2020CfraDowngradeHold ➝ SellLow
5/26/2020MizuhoInitiated CoverageBuy$35.00Low
5/12/2020HC WainwrightLower Price TargetNeutral$32.00 ➝ $26.00High
4/22/2020BenchmarkInitiated CoverageBuy$26.00Medium
3/30/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$18.00 ➝ $20.00Low
3/4/2020BarclaysInitiated CoverageOverweight$30.00High
2/28/2020Piper SandlerReiterated RatingBuy$35.00High
2/28/2020BTIG ResearchLower Price TargetBuy$101.00 ➝ $80.00High
2/28/2020William BlairReiterated RatingOutperformHigh
2/28/2020CowenReiterated RatingBuy$27.00Low
11/12/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$20.00 ➝ $24.00Medium
11/7/2019Piper Jaffray CompaniesLower Price TargetOverweight$50.00 ➝ $35.00High
8/11/2019Evercore ISIReiterated RatingHold$37.00High
8/9/2019BMO Capital MarketsLower Price TargetOutperform$75.00 ➝ $41.00High
8/9/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$59.00 ➝ $23.00High
4/20/2018Seaport Global SecuritiesInitiated CoverageBuy$120.00Low
11/15/2017Canaccord Genuity Group Inc. (CF.TO)Boost Price TargetBuy$35.00 ➝ $50.00N/A
11/13/2017Roth CapitalSet Price TargetBuy$45.00N/A
(Data available from 10/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.